Hepatoma cells |
HAV |
Genomic RNA, viral particles |
Viral spread |
Longatti et al., 2015 (ref. 52) |
Hepatoma cells |
HBV |
mRNA |
Viral spread |
Kapoor et al., 2017 (ref. 53); Yang et al., 2017 (ref. 54) |
Hepatoma cells |
HCV |
Full-length genomic RNA |
Viral spread |
Ramakrishnaiah et al., 2013 (ref. 55); Dreux et al., 2012 (ref. 56) |
Dendritic cells/lymphocytes |
HIV-1 |
Viral particles |
Immune escape and viral spread |
Wiley et al., 2006 (ref. 59); Arenaccio et al., 2015 (ref. 60); Sampey et al., 2016 (ref. 61) |
Liver cancer cells |
HSV-1 |
Viral mRNA and microRNAs |
Viral spread |
Kalamvoki et al., 2014 (ref. 62) |
T cells |
HTLV-1 |
mRNA and microRNAs |
Viral spread |
Jaworski et al., 2014 (ref. 63) |
Nasopharyngeal carcinoma cells/lymphoblastoid B lymphocytes |
EBV |
mRNA and microRNAs |
Immune escape and viral spread |
Canitano et al., 2013 (ref. 64); Ahmed et al., 2014 (ref. 65); Pegtel et al., 2010 (ref. 57) |
Kidney epithelial cells |
RVFV |
mRNA |
Viral spread |
Ashan et al., 2016 (ref. 66) |
Kidney cells |
FMDV |
Genomic RNA |
Inmune evasion |
Zhang et al., 2019 (ref. 67) |
Kidney cells |
PRRSV |
Genomic RNA |
Viral spread an inmune evasion |
Wang et al., 2018 (ref. 68) |